최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국생물공학회지 = Korean journal of biotechnology and bioengineering, v.19 no.6 = no.89, 2004년, pp.415 - 420
심두희 (신라대학교 생명공학과) , 이재화 (신라대학교 생명공학과)
All around the world, the rate of attack of cancer diseases has been going up and the number of cancer patients has been increasing every year. Cancer can be divided into malignant tumor and benign tumor according to its growth appearance. Many studies and experiments have been conducted and the var...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
International Agency for Research on Cancer-WHO. Cancer research for cancer control. IARC, Lyon, France, 2001
Yoo, K. Y. and H. R. Shin (2003), Cancer Epidemiology and Prevention, Kor. J. Epidem. 25(1), 1-15
Suh, H. S. and M. D. (1993), The Role of Radiation Therapy in Cancer Management, Inje. Med. J. 4(3), 253-258
Bae, J. M. and J. P. Kim (1998), Effect of adjuvant immunochemotherapy on immunologic function of gastric cancer patients, Kor. Sur. Society 55(2), 190-197
Finn, O. J. (2004), Tumor immunology Tumor immunology at the service of cancer immunotherapy, Curr. Opin. Immunol. 16, 1-3
Gunzer, M. et al. (2001), Dendritic cells and tumor immunity immunology, Immunology 13, 291-302
Singh, M. and D. O'Hagan (1999), Advances in vaccine adjuvants, Nat. Biotechnol. 17, 1075-1081
Schijins, V. E. (2000), Immunological concepts of vaccine adjuvant activity, Curr. Opin. Immunol. 12, 456-463
Krueger, C. et al. (2004), Quality and quantity: new strategies to improve immunotherapy of cancer, TRENDS in Mol. Med. 10(5), 205-208
Hsueh, E. C., R. K. Gupta, K. Qi, D. L. Morton (1998), Correlation of specific immune responses with survival in melanoma patients with distant metastases receiving polyvalent melanoma cell vaccine, J. Clin. Oncol. 16, 2913-2920
Soiffer, R. et al. (2003), Vaccination With Irradiated, Autologous Melanoma Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor by Adenoviral-Mediated Gene Transfer Augments Antitumor Immunity in Patients With Metastatic Melanoma, J. Clin. Oncol. 21(17), 3343-3350
Belli, F. et al. (2002), Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings, J. Clin. Oncol. 20(20), 4169-4180
Antonia, S., J. J. Mule, and S. Weber (2004), Current developments of immunotherapy in the clinic, Curr. Opin. Immunol. 16, 1-7
Pulendran, B., K. Palucka, and J. Banchereau (2001), Sensing pathogenes and tuning immune responses, Science 293(5528), 253-256
Banchereau. J. and R. M. Steinman (1998), Dendritic cells and the control of immunity, Nature 392, 245-252
Finn, O. J. (2003), Cancer vaccines: between the idea and the reality, Nat. Rev. Immunol. 3(8), 630-641
Wick, M. et al. (1997), Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy, J. Exp. Med. 186(2), 229-238
Enk, A. H., H. Jonuleit, J. Saloga, and J. Knop (1997), Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma, Int. J. Cancer. 73(3), 309-316
Lee, P. P. et al. (1999), Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients, Nat. Med. 5, 677-685
Knuth, A., T. Wolfel, and E. Klemann et al. (1989), Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection, Proc. Natl. Acad. Sci. USA 86(8), 2804-2808
O'Doherty, U. et al. (1994), Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature, Immunology 82, 878-884
Jefford, M., E. maraskovsky, J. Cebon, and I. D. Davis (2001), The use of dendritic cells in cancer therapy. Lancet Oncol. 2, 343-353
Jung, S. (2004), Good, Bed and beautiful-the role of dendritic cells in autoimmunity, Autoimmunity Rev. 3, 54-60
Martins, M. T. and A. L. Witzel, et al. (2004), Dendritic cell sarcoma of the oral cavity, Oral. Oncol. 40, 341-347
Dallal, R. M. and M. T. Lotze (2000), The dendritic cell and human cancer vaccines, Curr. Opin. Immunol. 12, 583-588
Carbone, F. R. and W. R. Heath (2003), The role of dendritic cell subsets in immunity to virus, Curr. Opin. Immunol. 15, 416-420
Steinman, R. M. and M. Pope (2002), Exploiting dendritic cells to improve vaccine efficacy, J. Clin. Invest. 109(12), 1519-1526
Hwang, J. W., M. Kim, K. Kim (1998), T cell epitope analysis of structural protein of adenovirus, Kor. J. Immunol. 20(4), 435-442
Banchereau, J., R. M. Steinman (1998), Dendritic cells and the control of immunity, Nature 392, 245-252
Yuji, T., T. Masatoshi et al. (2003), T-cell-dependent antitumor effects produced by CD40 ligand expressed on mouse lung carcinoma cells are linked with the maturation of dendritic cells and secretion of a variety of cytokines, Cancer Gene Ther. 10, 451-456
Terabe, M. and J. A. Berzofsky (2004), Immunoregulatory T cells in Tumor Immunity, Curr. Opin. Immunol. 16, 1-6
Maus, M. V., J. L. Riley, and C. H. June et al. (2003), HLA teramer-based artificial antigen-presenting cells for stimulation of CD4+ T cells, Clin. Immunol. 106, 16-22
Bozza, S. and L. Romani et al. (2004), Dendritic cell-based vaccination against opportunistic fungi, Vaccine 22, 857-864
Kjaergaard, J., K. Shimizu, and S. Shu (2003), Electrofusion of syngeneic dendritic cells and tumor generates potent therapeutic vaccine, Cell. Immunol. 255, 65-74
Thumann, P. I. Moc and L. Jenne et al. (2003), Antigen loading of dendritic cells with whole tumor cell preparations, J. Immunol. Methods 277, 1-16
Nastle, F. O., S. Alijagic, and M. Gilliet et al. (1998), Vaccination of melanoma patients with peptide- or tumor-lysate plused dendritic cells, Nat. Med. 4, 328-332
Sadanaga, N. et al. (2001), Dendritic cell vaccination with MAGE peptides is a novel therapeutic approach for gastrointestinal carcinomas, Clin. Cancer. Res. 7, 2277-2284
Boon, T. and B. V. Eynde (2003), Tumor Immunology, Curr. Opin. Immunol. 15, 129-130
Yan, X., B. D. Johnson, and R. J. Orentas (2004), Murine CD8 lymphocyte expansion in vitro by artificial antigen-presenting cells expressing CD137L (4-1BBL) is superior to CD28, and CD137L expression on neuroblastoma expands CD8 tumor-reactive effector cells in vivo, Immunology 112(1), 105-116
Orchard, P. J. et al. (2002), Clinical-scale selection of anti-CD3 /CD28-activated T cells after transduction with a retroviral vector expressing herpes simplex virus thymidine kinase and truncated nerve growth factor receptor, Hum. Gene Ther. 13(8), 979-988
Ruffini, P. A. and L. W. Kwak (2001), Immunotheraphy of multiple myeloma, Semin. Hematol. 38, 260-267
Ratta, M. et al. (2002), Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6, Blood 100, 230-237
May, K. F., Jr., L. Chen, P. Zheng, and Y. Lui (2002), Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by priming survival but not clonal expansion of tumor-specific CD8+ T cells, Cancer Res. 62, 3459-3465
Bella, S. D. et al. (2003), Altered maturation of peripheral blood dendritic cells in patients with breast cancer, Br. J. cancer. 89, 1463-1472
Oleike, M. et al. (2003), Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells, Nature 9(5), 619-625
※ AI-Helper는 부적절한 답변을 할 수 있습니다.